MoneyWorks4Me

Syschem (India) informs about certificate

16 Apr 2025 Evaluate

Pursuant to relevant Regulation of SEBI (Listing Obligation and Disclosure requirements), 2015, Syschem (India) has informed that it attached the Fund Utilization certificate from the Statutory Auditor of the Company, in relation to the Preferential Issue of Convertible Warrants of the Company. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..